About Nucleus Formulation
Nucleus Formulation was a Healthcare company based in Gandhinagar (India) founded in 2009 by Jayesh Pandya. It manufactures pharmaceutical formulations for therapeutic needs and exports worldwide. It operates on a B2B and Export model. The company has 13 employees. Its Indian entity Nucleus Formulation Private Limited reported revenue of ₹5.79 Cr. The company is recorded as dissolved. Nucleus Formulation offers products and services including Analgesic Products, Anti-Fungal Products, Cardiovascular Products, Gastro-Intestinal Products, and Gynecology Supplements. Its focus areas include Pharmaceuticals, Formulations, Generic Drugs and Therapeutics. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Nucleus Formulation Pvt. Ltd. is a leading pharmaceutical company based in Gujarat, India, specializing in manufacturing tablets, capsules, and other formulations for areas like diabetology, pain management, and anti-infectives. They operate through contract manufacturing and exports, serving markets in Africa, Asia, and South America while maintaining high safety and quality standards. Their global presence includes partnerships in emerging markets, focusing on generic drugs and therapeutic solutions.
- Headquarters Gandhinagar, India
- Employees 13
- Founders Jayesh Pandya
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nucleusformulation.com
- Legal Name Nucleus Formulation Private Limited
- Date of Incorporation 13 Jul, 2009
- Jurisdiction Chhatral, Gujarat, India
- Annual Revenue₹5.79 Cr
FY 2025 · +14% YoY
- Net Profit₹14.9 Lakh
FY 2025 · 3% margin
- EBITDA₹56.5 Lakh
FY 2025 · 10% margin
- Employee Count13
Associated legal entities of Nucleus Formulation
Nucleus Formulation operates through Nucleus Formulation Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nucleus Formulation Private Limited CIN U24239GJ2009PTC057517 | Active | 13 Jul 2009 | Chhatral, Gujarat | ₹5.8 Cr | 13 | 2 | View details |
Products & Services of Nucleus Formulation
Nucleus Formulation offers a comprehensive portfolio of products and services, including Analgesic Products, Anti-Fungal Products, Cardiovascular Products, Gastro-Intestinal Products, and Gynecology Supplements.
Medications for relieving pain and inflammation.
Treatments against fungal infections.
Formulations for managing cardiovascular conditions.
Solutions for gastrointestinal disorders.
Supplements for gynecological needs.
Board of directors of Nucleus Formulation Private Limited (Nucleus Formulation)
Nucleus Formulation Private Limited is the primary company behind Nucleus Formulation. The board of Nucleus Formulation Private Limited currently have 2 directors; the longest-serving is Jitendra Lavjibhai Patel, appointed in 2009. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jitendra Lavjibhai Patel DIN 02681080 | Director | 13 Jul 2009 | 17 yrs 3 mo | Nucleus Formulation Private Limited |
| Dipesh Jyotindrakumar Thakar DIN 02671890 | Director | 13 Jul 2009 | 17 yrs 3 mo | Nucleus Formulation Private Limited |
People of Nucleus Formulation
1 people are tracked at Nucleus Formulation (1 in leadership); the tracked headcount is 13.
| Name | Role | Group |
|---|---|---|
| Founder, Director | Leadership |
Complete people profiles for Nucleus Formulation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Nucleus Formulation
Figures of Nucleus Formulation Private Limited, the primary company behind Nucleus Formulation, for FY 2025. Revenue was ₹5.79 Cr (+14% year on year). Net profit was ₹14.9 Lakh (3% margin). EBITDA was ₹56.5 Lakh (10% margin). Revenue has grown at a compounded annual rate of -14% over three years and -7% over five years.
- ₹5.79 CrRevenue · FY 2025 · +14% YoY
- ₹14.9 LakhNet profit · 3% margin
- ₹56.5 LakhEBITDA · 10% margin
- ₹50 LakhPaid-up capital
- 13Employees (provident fund records)
- -14%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nucleus Formulation Private Limited are on its company page.
Detailed financial statements for Nucleus Formulation
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Nucleus Formulation
Nucleus Formulation has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Nucleus Formulation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nucleus Formulation
Nucleus Formulation was founded in 2009.
Nucleus Formulation is headquartered in Gandhinagar, India. It is registered at Gandhinagar, Gujarat, India.
Nucleus Formulation has 13 employees.
The primary company behind Nucleus Formulation, Nucleus Formulation Private Limited, reported revenue of ₹5.79 Cr for FY 2025, up 14% year on year.
Nucleus Formulation Pvt. Ltd. is a leading pharmaceutical company based in Gujarat, India, specializing in manufacturing tablets, capsules, and other formulations for areas like diabetology, pain management, and anti-infectives. They operate through contract manufacturing and exports, serving markets in Africa, Asia, and South America while maintaining high safety and quality standards. Their global presence includes partnerships in emerging markets, focusing on generic drugs and therapeutic solutions.
Nucleus Formulation's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Nucleus Formulation offers Analgesic Products, Anti-Fungal Products, Cardiovascular Products, Gastro-Intestinal Products, and Gynecology Supplements.
Nucleus Formulation operates through Nucleus Formulation Private Limited.
The legal entities of Nucleus Formulation currently have 2 directors, including Jitendra Lavjibhai Patel, Dipesh Jyotindrakumar Thakar.